Developing an automated robotic factory for novel stem cell therapy production

Written by Regenerative Medicine

Editorial discussing the need for new, advanced manufacturing platforms to be developed in order for advanced stem cell therapies, that is, cell and gene therapies, to achieve widespread clinical application, by Qasim A Rafiq, Karen Twomey, Michael Kulik et al. (from various organizations such as Fraunhofer Institute for Production Technology IPT in Germany and Cell & Gene Therapy Catapult in the UK). Cell and gene therapies could treat conditions that currently have unmet need, such as many age-associated diseases, and thereby could provide not just socioeconomic as well as patient health benefit. However, expected manufacture of these advanced therapies needs...

To view the full article, please register now for access

It's completely free